Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search
Stanley H. Appel

Stanley H. Appel

individual
Ecosystem influencer

About

Stanley H. Appel, M.D., is a neurologist and ALS researcher based at Houston Methodist whose work has focused on ALS, Parkinson's disease, Alzheimer's disease, and neuroinflammation. He established what became the Houston Methodist Neurological Institute's MDA ALS Research and Clinical Center and has also served as Director of the Ann Kimball and John W. Johnson Center for Cellular Therapeutics at Houston Methodist. In industry, he is publicly associated with Coya Therapeutics and BrainStorm Cell Therapeutics in scientific advisory roles tied to neurodegenerative disease therapeutics.

Areas of interest

ALSneurologyneurodegenerationParkinson's diseaseAlzheimer's diseaseregulatory T-cell therapeuticscell therapyneuroinflammation